| Authors: |
Palefsky JM; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Giuliano AR; Center for Immunization and Infection Research in Cancer (CIIRC), Moffitt Cancer Center, Tampa, Florida, USA., Goldstone SE; Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dubin B; Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, USA., Saah A; Global Medical and Scientific Affairs, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, USA., Luxembourg A; Vaccine Clinical Development, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, USA., Velicer C; Department of Epidemiology, Biostatistics and Research Decision Sciences, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, USA., Tota JE; Department of Epidemiology, Biostatistics and Research Decision Sciences, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, USA. |